RP
REGENERON PHARMACEUTICALS
REGN· Health Care· BiotechnologyS&P 500
Close · 10/09/2026
793.26
1D
-1.78%52-week range
541 – 859.34
Volume
5,26,900.00
Price history
REGN
11/08/2026 to 10/09/2026
O 794.36 H 806.14 L 792.00
1W-6.90%
1M-0.47%
3M+31.85%
6M+2.40%
1Y+42.54%
3Y-3.60%
5Y+16.49%
MAX+37.98%
Fundamentals
as of 10/09/2026- Market cap
- $74.53B
- Shares out
- 93.96M
- P/E (trailing)
- 17.22
- P/E (forward)
- 13.66
- EPS (trailing)
- 46.07
- Dividend yield
- 0.47%
- Beta
- 0.19
- Profit margin
- 27.86%
- P/B
- 2.35
- Return on equity
- 13.65%
SEC financial statements
63 quarterly and 18 annual periods through 30/06/2026.
Details
- Ticker
- REGN
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 10/09/2026.
Tracked by Congress
12 filers · 2 on watchlist · 12 buys · 22 sells · ?: 1 · D: 25 · R: 8
- 27/03/2026Alan ArmstrongBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 15/05/2026Gilbert CisnerosSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 12/02/2026Julia LetlowBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 18/11/2025Gilbert CisnerosBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 15/05/2025Rob BresnahanBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 10/04/2025Byron DonaldsSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 10/04/2025Byron DonaldsSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 01/04/2025Julie JohnsonSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000